BRCA1 promoter methylation in blood-derived DNA is associated with a 3.5-fold (95% CI, 1.4–10.5) increased risk for early-onset breast cancer with histological features commonly seen in tumors arising in women with germline BRCA1 mutations [3]. This evidence concerns the gene BRCA1 and breast cancer.